These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 863167
1. [Evaluation of the immunological capacity in patients with cervical-uterine cancer under conventional treatment. Analysis of 38 cases]. Jiménez-Zamudio L, Castro-Mussot MA, Fávila-Castillo L, Gutiérrez-Gómez A, Pulido-Villegas I, García-García G. Gac Med Mex; 1977 Feb; 113(2):77-82. PubMed ID: 863167 [No Abstract] [Full Text] [Related]
2. [Changes in the heterophile antibody titer in patients with cancer of the uterine cervix during radiation therapy]. Luginina AS, Nesyn IN, Zakler EI. Vopr Onkol; 1969 Feb; 15(1):37-40. PubMed ID: 5784516 [No Abstract] [Full Text] [Related]
3. [Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation (author's transl)]. Palencia C, Wicke L, Kärcher KH, Gitsch E, Hernuss P, Steffen C. Wien Klin Wochenschr; 1976 Aug 13; 88(15):495-501. PubMed ID: 997530 [Abstract] [Full Text] [Related]
5. Immunological reactions after irradiation of the uterus. Einhorn N, Jonsson J, Fagraeus A. Radiat Res; 1969 Nov 13; 40(2):465-72. PubMed ID: 4898745 [No Abstract] [Full Text] [Related]
6. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer]. Wang Y, Li X, Chen W. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 13; 26(1):16-21. PubMed ID: 16495168 [Abstract] [Full Text] [Related]
7. Humoral immunity in patients with carcinoma of the uterine cervix--effects of radiation therapy. Juranić Z, Vucković-Dekić L, Durbaba M. Neoplasma; 1993 Jan 13; 40(5):297-300. PubMed ID: 8272158 [Abstract] [Full Text] [Related]
8. [Stimulation of a built-in body defence mechanism against carcinoma of the cervix: a clinical experimental study (author's transl)]. Michalica W. Wien Klin Wochenschr Suppl; 1974 Jan 13; 29():1-30. PubMed ID: 4530548 [No Abstract] [Full Text] [Related]
9. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls. Kawana T, Cornish JD, Smith MF, Aurelian L. Cancer Res; 1976 Jun 13; 36(6):1910-4. PubMed ID: 1268845 [Abstract] [Full Text] [Related]
10. [Effects of lysozyme chloride on immune responses of patients with uterine cervical cancer]. Yamaoka K, Yoshioka T. Gan To Kagaku Ryoho; 1983 Aug 13; 10(8):1803-9. PubMed ID: 6882004 [Abstract] [Full Text] [Related]
11. Re: Aloysius MM, Robins RA, Eremin JM, Eremin O. Vaccination therapy in malignant disease. Surgeon 2006; 4(5): 309-20. Adeyemi O, Adeniyi JO, Chin KA. Surgeon; 2007 Jun 13; 5(3):191; author reply 191. PubMed ID: 17575674 [No Abstract] [Full Text] [Related]
12. [Immunoenzymatic detection of IgA and IgG antibodies to HSV-1, HSV-2 in sera of patients with cervical cancer (author's transl)]. Fan J, Zeng Y, Liu YF. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Feb 13; 4(1):50-2. PubMed ID: 6279319 [No Abstract] [Full Text] [Related]
13. Immune reactive proteins in patients irradiated for cervical cancer. One year follow up. Juranić Z, Vucković-Dekić L, Durbaba M. Neoplasma; 1994 Feb 13; 41(4):225-8. PubMed ID: 7935997 [Abstract] [Full Text] [Related]
14. T gamma cell levels in mammary and cervical uterine cancer patients before and after local irradiation treatment. Folch H, Armando S, Cardemil B, Eller G, Ojeda F. Allergol Immunopathol (Madr); 1984 Feb 13; 12(5):383-6. PubMed ID: 6335357 [Abstract] [Full Text] [Related]
15. [Serological aspects of the relation between herpes virus and cervico-uterine cancer]. Suárez M, Del Campo G, Ojeda JM. Rev Chil Obstet Ginecol; 1983 Feb 13; 48(1):11-5. PubMed ID: 6099904 [No Abstract] [Full Text] [Related]
16. Natural killer lymphocyte function in cervical cancer patients. Pulay TA, Benczur M, Varga M. Neoplasma; 1982 Feb 13; 29(2):237-40. PubMed ID: 7110449 [Abstract] [Full Text] [Related]
17. [The influence of radiotherapy on T lymphocyte subpopulations analyzed by monoclonal antibodies]. Shikaura S, Sogawa M, Akagi K, Hasegawa T, Sawada S, Tanaka Y, Sawaragi I. Gan No Rinsho; 1988 Mar 13; 34(3):305-9. PubMed ID: 3258643 [Abstract] [Full Text] [Related]
18. [Irradiated cases of cervical and breast cancer II. Comparative investigation of the immune status of irradiated cases with stage III cancer of the cervix and operated, non-irradiated cases (author's transl)]. Palencia C, Hernuss P, Gitsch E, Weghaupt K, Wicke L, Kärcher KH, Steffen C. Wien Klin Wochenschr; 1975 Dec 26; 87(24):809-15. PubMed ID: 1084083 [Abstract] [Full Text] [Related]
19. [Clinical evaluation of serum CEA levels in uterine cervix cancer]. Kikuchi Y, Hirose J, Uekita Y, Hayasaka K, Asano A, Nishino S, Mitsuhashi H, Amo K, Washizuka N, Mure I, Yamashita Y. Gan No Rinsho; 1983 Apr 26; 29(4):A-21, 330-5. PubMed ID: 6854968 [Abstract] [Full Text] [Related]
20. [Effect of laser therapy on immunoreactivity in precaner and preinvasive cancer of the cervix uteri]. Shcherbitskaia LL, Dziubko NIa, Alferov AN, Tarasiuk OT. Vrach Delo; 1981 Jul 26; (7):8-11. PubMed ID: 6974433 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]